• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.33% Nasdaq Up 1.33%

    AbbVie Inc. (ABBV)

    -NYSE
    61.91 Up 0.10(0.16%) Jun 30, 4:01PM EDT
    Prev Close:61.81
    Open:61.79
    Bid:58.54 x 100
    Ask:65.06 x 100
    1y Target Est:70.00
    Beta:1.46627
    Next Earnings Date:29-Jul-16ABBV Earnings announcement
    Day's Range:61.14 - 62.02
    52wk Range:45.45 - 71.60
    Volume:7,920,605
    Avg Vol (3m):8,704,360
    Market Cap:104.02B
    P/E (ttm):18.61
    EPS (ttm):3.33
    Div & Yield:2.28 (3.81%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABBV

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 0.16%104.02B
    PFEUp 0.57%213.54B
    MRKUp 0.98%159.47B

    Key Statistics

    Forward P/E (1 yr):11.04
    P/S (ttm):4.20
    Ex-Dividend Date:13-Apr-16

    Analysts

    Annual EPS Est (Dec-16) :4.76
    Quarterly EPS Est (Jun-16) :1.20
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the trea... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback